On the other hand, EVs released following cytochalasin B treatment from human adipose tissue-derived MSCs, genetically modified to overexpress interleukin-2 (IL2), were shown to activate and stimulate the proliferation of T-killer cells, which in turn were able to induce apoptosis in breast cancer cells [139]. This evidence concerns the gene IL2 and breast carcinoma.